J Immunol. 2008 Jan 1;180(1):72-8.

Immunotherapy with chimeric NKG2D receptors leads to long-term tumor-free survival and development of host antitumor immunity in murine ovarian cancer.

Source

Department of Microbiology and Immunology, Dartmouth Medical School, Lebanon, NH 03756, USA.

Abstract

Ovarian cancer is one of the leading causes of cancer death in women and the development of novel therapies is needed to complement the standard treatment options such as chemotherapy and radiation. In this study, we show that treatment with T cells expressing a chimeric NKG2D receptor (chNKG2D) was able to lead to long-term, tumor-free survival in mice bearing established ovarian tumors. Tumor-free mice were able to reject a rechallenge with ovarian tumor cells 225 days after original tumor injection. In addition, chNKG2D T cell treatment induced specific host immune responses to ovarian tumor cells, including the development of both CD8+ and CD4+ T cell tumor-specific memory responses. The chNKG2D T cells reduced the ovarian tumor burden using both cytotoxic and cytokine-dependent pathways. Specifically, chNKG2D T cell expression of perforin, GM-CSF, and IFN-gamma were essential for complete antitumor efficacy.

PMID:: 18097006; [PubMed - indexed for MEDLINE]

Free full text

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

MeSH Terms

Substances

Grant Support

AI 07363/AI/NIAID NIH HHS/United States

LinkOut - more resources

Full Text Sources

HighWire Press

Other Literature Sources

COS Scholar Universe

Medical

Supplemental Content

Related citations

Chimeric NKG2D receptor-bearing T cells as immunotherapy for ovarian cancer. [Cancer Res. 2007]
Chimeric NKG2D receptor-bearing T cells as immunotherapy for ovarian cancer.
Barber A, Zhang T, DeMars LR, Conejo-Garcia J, Roby KF, Sentman CL. Cancer Res. 2007 May 15; 67(10):5003-8.
Chimeric NKG2D T cells require both T cell- and host-derived cytokine secretion and perforin expression to increase tumor antigen presentation and systemic immunity. [J Immunol. 2009]
Chimeric NKG2D T cells require both T cell- and host-derived cytokine secretion and perforin expression to increase tumor antigen presentation and systemic immunity.
Barber A, Sentman CL. J Immunol. 2009 Aug 15; 183(4):2365-72. Epub 2009 Jul 22.
Chimeric NKG2D modified T cells inhibit systemic T-cell lymphoma growth in a manner involving multiple cytokines and cytotoxic pathways. [Cancer Res. 2007]
Chimeric NKG2D modified T cells inhibit systemic T-cell lymphoma growth in a manner involving multiple cytokines and cytotoxic pathways.
Zhang T, Barber A, Sentman CL. Cancer Res. 2007 Nov 15; 67(22):11029-36.
Review The role of the NKG2D receptor for tumor immunity. [Semin Cancer Biol. 2006]
Review The role of the NKG2D receptor for tumor immunity.
Coudert JD, Held W. Semin Cancer Biol. 2006 Oct; 16(5):333-43. Epub 2006 Jul 8.
Review Adoptive T cell immunotherapy strategies for the treatment of patients with ovarian cancer. [Discov Med. 2010]
Review Adoptive T cell immunotherapy strategies for the treatment of patients with ovarian cancer.
Chekmasova AA, Brentjens RJ. Discov Med. 2010 Jan; 9(44):62-70.

See reviews... See all...

Cited by 5 PubMed Central articles

Successful eradication of established peritoneal ovarian tumors in SCID-Beige mice following adoptive transfer of T cells genetically targeted to the MUC16 antigen. [Clin Cancer Res. 2010]
Successful eradication of established peritoneal ovarian tumors in SCID-Beige mice following adoptive transfer of T cells genetically targeted to the MUC16 antigen.
Chekmasova AA, Rao TD, Nikhamin Y, Park KJ, Levine DA, Spriggs DR, Brentjens RJ. Clin Cancer Res. 2010 Jul 15; 16(14):3594-606. Epub 2010 Jul 13.
Chimeric NKG2D expressing T cells eliminate immunosuppression and activate immunity within the ovarian tumor microenvironment. [J Immunol. 2009]
Chimeric NKG2D expressing T cells eliminate immunosuppression and activate immunity within the ovarian tumor microenvironment.
Barber A, Rynda A, Sentman CL. J Immunol. 2009 Dec 1; 183(11):6939-47. Epub 2009 Nov 13.
Chimeric NKG2D T cells require both T cell- and host-derived cytokine secretion and perforin expression to increase tumor antigen presentation and systemic immunity. [J Immunol. 2009]
Chimeric NKG2D T cells require both T cell- and host-derived cytokine secretion and perforin expression to increase tumor antigen presentation and systemic immunity.
Barber A, Sentman CL. J Immunol. 2009 Aug 15; 183(4):2365-72. Epub 2009 Jul 22.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Immunotherapy with chimeric NKG2D receptors leads to long-term tumor-free surviv...
Immunotherapy with chimeric NKG2D receptors leads to long-term tumor-free survival and development of host antitumor immunity in murine ovarian cancer.
J Immunol. 2008 Jan 1 ;180(1):72-8.

PubMed
Polyethylenimine-based siRNA nanocomplexes reprogram tumor-associated dendritic ...
Polyethylenimine-based siRNA nanocomplexes reprogram tumor-associated dendritic cells via TLR5 to elicit therapeutic antitumor immunity.
J Clin Invest. 2009 Aug ;119(8):2231-44. doi: 10.1172/JCI37716. Epub 2009 Jul 13 .

PubMed
Spinal extension exercises prevent natural progression of kyphosis.
Spinal extension exercises prevent natural progression of kyphosis.
Osteoporos Int. 2009 Mar ;20(3):481-9. Epub 2008 Jul 26 .

PubMed
Effect of dietary trans fatty acids on high-density and low-density lipoprotein ...
Effect of dietary trans fatty acids on high-density and low-density lipoprotein cholesterol levels in healthy subjects.
N Engl J Med. 1990 Aug 16 ;323(7):439-45.

PubMed
Phosphorylation by protein kinase a inhibits nuclear import of 5-lipoxygenase.
Phosphorylation by protein kinase a inhibits nuclear import of 5-lipoxygenase.
J Biol Chem. 2005 Dec 9 ;280(49):40609-16. Epub 2005 Oct 17 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to: